Revelation Biosciences REVB
NASDAQ REVB
$3.70 +0.10 (+2.78%)
As of: Oct 22, 2026 · 12:28 PM EDT

Revelation Biosciences (REVB) FCF Margin (2025 - 2026)

Updated

Analysis

Revelation Biosciences (REVB) FCF Margin (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,170.90 Bn 1,139.49 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 643.26 Bn 561.78 Bn 17.26 Bn 28.82%
3 AbbVie 501.85 Bn 474.96 Bn 12.70 Bn 18.33%
4 Merck 370.72 Bn 325.10 Bn 12.21 Bn 26.96%
5 Novartis Ag 302.56 Bn 266.55 Bn 11.24 Bn 38.60%
6 Astrazeneca 268.35 Bn 242.04 Bn 12.86 Bn 6.55%
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn 34.70%
8 Gilead Sciences 193.22 Bn 167.42 Bn 6.22 Bn 44.00%
9 Pfizer 172.25 Bn 118.90 Bn 10.94 Bn 2.01%
10 Revelation Biosciences 14.17 Mn -34.85 Mn - -3,160.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,160.73%
Jun 30, 2025 -9,756.41%
API Access

Revelation Biosciences FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=REVB&period=max&api_key=YOUR_API_KEY